These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34395283)

  • 1. Leukemia With
    Lin N; Yan X; Cai D; Wang L
    Front Oncol; 2021; 11():709036. PubMed ID: 34395283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc finger protein 384 (
    Sudutan T; Erbilgin Y; Hatirnaz Ng O; Karaman S; Karakas Z; Kucukcankurt F; Celkan T; Timur C; Ozdemir GN; Hacısalihoglu S; Gelen SA; Sayitoğlu M
    Leuk Lymphoma; 2022 Dec; 63(12):2931-2939. PubMed ID: 35921545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.
    Hirabayashi S; Ohki K; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yaguchi A; Terada K; Saito Y; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fujimura J; Hino M; Kinoshita A; Kakuda H; Kurosawa H; Kato K; Kajiwara R; Moriwaki K; Morimoto T; Nakamura K; Noguchi Y; Osumi T; Sakashita K; Takita J; Yuza Y; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Fukushima T; Koh K; Manabe A; Ohara A; Kiyokawa N;
    Haematologica; 2017 Jan; 102(1):118-129. PubMed ID: 27634205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
    Oberley MJ; Gaynon PS; Bhojwani D; Pulsipher MA; Gardner RA; Hiemenz MC; Ji J; Han J; O'Gorman MRG; Wayne AS; Raca G
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27265. PubMed ID: 29797659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B/ZNF384 gene fusion.
    Shago M; Abla O; Hitzler J; Weitzman S; Abdelhaleem M
    Pediatr Blood Cancer; 2016 Nov; 63(11):1915-21. PubMed ID: 27392123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
    Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
    Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
    Wang Q; Cai WZ; Wang QR; Zhu MQ; Yan LZ; Yu Y; Bao XB; Shen HJ; Yao H; Xie JD; Zhang TT; Zhang L; Xu XY; Shan Z; Liu H; Cen JN; Liu DD; Pan JL; Lu DR; Chen J; Xu Y; Zhang R; Wang Y; Xue SL; Miao M; Han Y; Tang XW; Qiu HY; Sun AN; Huang JY; Dai HP; Wu DP; Chen SN
    Am J Hematol; 2023 Jan; 98(1):66-78. PubMed ID: 36219502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of EP300-ZNF384 fusion in patients with acute lymphoblastic leukemia using RNA fusion gene panel sequencing.
    Jing Y; Li YF; Wan H; Liu DH
    Ann Hematol; 2020 Nov; 99(11):2611-2617. PubMed ID: 32980888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.
    Mumme HL; Raikar SS; Bhasin SS; Thomas BE; Lawrence T; Weinzierl EP; Pang Y; DeRyckere D; Gawad C; Wechsler DS; Porter CC; Castellino SM; Graham DK; Bhasin M
    Genome Med; 2023 Oct; 15(1):83. PubMed ID: 37845689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of TCF3-ZNF384 fusion by transcriptome sequencing in B cell acute lymphoblastic leukemia and its laboratory and clinical characteristics].
    Wu Q; Wang F; Yang J; Chen X; Ma X; Cao P; Zhang Y; Nie D; Chen J; Zhou X; Fang J; Liu M; Zhang M; Wu P; Wang T; Liu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Apr; 38(4):351-354. PubMed ID: 33834463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia.
    Janet NB; Kulkarni U; Arun AK; Bensega B; Devasia AJ; Korula A; Abraham A; George B; Mathews V; Balasubramanian P
    Int J Lab Hematol; 2021 Aug; 43(4):658-663. PubMed ID: 33988307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZNF384 rearrangement in acute lymphocytic leukemia with renal involvement as the first manifestation is associated with a poor prognosis: a case report.
    Ma J; Guan J; Chen B
    Mol Cytogenet; 2022 Feb; 15(1):4. PubMed ID: 35164825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed Phenotype Acute Leukemia with t(12;17)(p13;q21)/TAF15-ZNF384 and Other Chromosome Abnormalities.
    Yamamoto K; Kawamoto S; Mizutani Y; Yakushijin K; Yamashita T; Nakamachi Y; Kawano S; Hayashi Y; Matsuoka H; Minami H
    Cytogenet Genome Res; 2016; 149(3):165-170. PubMed ID: 27607436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
    Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
    Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Characteristics of Patients with Ph
    Jia YN; Li Y; Gong XY; Liu KQ; Ye L; Wang HJ; Li QH; Li CW; Wang Y; Wang JX; Mi YC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):354-359. PubMed ID: 30998137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
    Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Landscape of Mixed-Phenotype Acute Leukemia.
    Hennawi M; Pakasticali N; Tashkandi H; Hussaini M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics And Outcome Of Biphenotypic Acute Leukemia: 10 Case Reports And Literature Review.
    Yu J; Li Y; Xing H; Pan Y; Sun H; Wan D; Liu Y; Xie X; Wang C; Sun L; Sun K; Jiang Z
    Cancer Manag Res; 2019; 11():9297-9306. PubMed ID: 31802948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
    Mejstrikova E; Volejnikova J; Fronkova E; Zdrahalova K; Kalina T; Sterba J; Jabali Y; Mihal V; Blazek B; Cerna Z; Prochazkova D; Hak J; Zemanova Z; Jarosova M; Oltova A; Sedlacek P; Schwarz J; Zuna J; Trka J; Stary J; Hrusak O
    Haematologica; 2010 Jun; 95(6):928-35. PubMed ID: 20145275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF384 fusion transcript levels for measurable residual disease monitoring in adult B-cell acute lymphoblastic leukemia.
    Shi ZY; Wang X; Chen WM; Li LD; Hao Y; Li JY; Sun K; Zhao XS; Jiang H; Jiang Q; Huang XJ; Qin YZ
    Hematol Oncol; 2024 Jan; 42(1):e3251. PubMed ID: 38287528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.